Cargando…

Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents

Cancer threatens human health and life. Therefore, it is particularly important to develop safe and effective antitumor drugs. Microtubules, the main component of cytoskeleton, play an important role in maintaining cell morphology, mitosis, and signal transduction, which are one of important targets...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chao, Shi, Lingyu, Yang, Shanbo, Chang, Jing, Liu, Wenjing, Zeng, Jun, Meng, Jingsen, Zhang, Renshuai, Xing, Dongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014799/ https://www.ncbi.nlm.nih.gov/pubmed/36936533 http://dx.doi.org/10.3389/fchem.2023.1096666

Ejemplares similares

Advances in antitumor research of CA-4 analogs carrying quinoline scaffold
por: Wang, Chao, et al.
Publicado: (2022)

The role of NPC1L1 in cancer
por: Zhang, Renshuai, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors
por: Shi, Lingyu, et al.
Publicado: (2022)

Recent Advances on the Role of ATGL in Cancer
por: Zhang, Renshuai, et al.
Publicado: (2022)

Inhibitory Effect of Isoliquiritigenin in Niemann-Pick C1-Like 1-Mediated Cholesterol Uptake
por: Zeng, Jun, et al.
Publicado: (2022)

Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors
por: Yang, Shanbo, et al.
Publicado: (2022)

First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor
por: Liu, Wenjing, et al.
Publicado: (2022)

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice
por: Semenchenko, Kostyantyn, et al.
Publicado: (2016)

XRP44X Enhances the Cytotoxic Activity of Natural Killer Cells by Activating the c-JUN N-Terminal Kinase Signaling Pathway
por: Kim, Kwang-Soo, et al.
Publicado: (2020)

Cryptoasset networks: Flows and regular players in Bitcoin and XRP
por: Aoyama, Hideaki, et al.
Publicado: (2022)

Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
por: Wang, Chao, et al.
Publicado: (2022)

Projecting XRP price burst by correlation tensor spectra of transaction networks
por: Chakraborty, Abhijit, et al.
Publicado: (2023)

EM-Measurements and Evaluation of the XRP (Roman Pot to be installed with UA9 Experiment)
por: Farricker, Aaron, et al.
Publicado: (2017)

Ripple quick start guide: get started with XRP and develop applications on Ripple's blockchain
por: James, Febin John
Publicado: (2018)

Drosophila RpS12 controls translation, growth, and cell competition through Xrp1
por: Ji, Zhejun, et al.
Publicado: (2019)

The transcription factor Xrp1 is required for PERK-mediated antioxidant gene induction in Drosophila
por: Brown, Brian, et al.
Publicado: (2021)

Biological Evaluation of Noscapine analogues as Potent and Microtubule-Targeted Anticancer Agents
por: Tomar, Vartika, et al.
Publicado: (2019)

Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents
por: Yan, Qi, et al.
Publicado: (2016)

Xrp1 genetically interacts with the ALS-associated FUS orthologue caz and mediates its toxicity
por: Mallik, Moushami, et al.
Publicado: (2018)

Xrp1 is a transcription factor required for cell competition-driven elimination of loser cells
por: Baillon, Ludovic, et al.
Publicado: (2018)

Cell competition is driven by Xrp1-mediated phosphorylation of eukaryotic initiation factor 2α
por: Ochi, Naotaka, et al.
Publicado: (2021)

Design, synthesis, and biological evaluation of biotinylated colchicine derivatives as potential antitumor agents
por: Wang, Chao, et al.
Publicado: (2021)

Xrp1 and Irbp18 trigger a feed-forward loop of proteotoxic stress to induce the loser status
por: Langton, Paul F., et al.
Publicado: (2021)

The Drosophila FUS ortholog cabeza promotes adult founder myoblast selection by Xrp1-dependent regulation of FGF signaling
por: Catinozzi, Marica, et al.
Publicado: (2020)

The transcription factor Xrp1 orchestrates both reduced translation and cell competition upon defective ribosome assembly or function
por: Kiparaki, Marianthi, et al.
Publicado: (2022)

Loss of Paip1 causes translation reduction and induces apoptotic cell death through ISR activation and Xrp1
por: Xue, Maoguang, et al.
Publicado: (2023)

From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents.
por: Corbin, A.
Publicado: (1982)

Exploring Carbohydrates for Therapeutics: A Review on Future Directions
por: Wang, Jie, et al.
Publicado: (2021)

Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges
por: Wang, Chao, et al.
Publicado: (2022)

Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent
por: Rickardson, Linda, et al.
Publicado: (2017)

Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin as Microtubule-Targeting Agents
por: Song, Ming-Yu, et al.
Publicado: (2020)

PROTACs for BRDs proteins in cancer therapy: a review
por: Wang, Chao, et al.
Publicado: (2022)

The antitumor activity of 4,4′-bipyridinium amphiphiles
por: Wang, Senlin, et al.
Publicado: (2019)

Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67
por: Cui, Minhu, et al.
Publicado: (2020)

Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site
por: Fu, Dong-Jun, et al.
Publicado: (2017)

Design, synthesis, and bioactivity evaluation of antitumor sorafenib analogues
por: Zhou, Shiyang, et al.
Publicado: (2018)

The Synthesis and Biological Evaluation of Aloe-Emodin-Coumarin Hybrids as Potential Antitumor Agents
por: Shang, Hai, et al.
Publicado: (2022)

Molecular basis of resistance to the microtubule-depolymerizing antitumor compound plocabulin
por: Pantazopoulou, Areti, et al.
Publicado: (2018)

Nucleoside Analogues as Antibacterial Agents
por: Thomson, Jessica M., et al.
Publicado: (2019)

Synthesis, DNA Binding and Antitumor Evaluation of Styelsamine and Cystodytin Analogues
por: Fong, Hugo K. H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v1qhdj0kv9pg48fbe8r8t8fcg2